Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

Oligoprogressive

Lung Cancer Metastatic

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Colorectal Neoplasms

Melanoma, Skin Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Colorectal Neoplasms

Hodgkin Disease

Biliary Tract Neoplasms

Fowlpox, Colorectal Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Lung Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Renal Cell

Carcinoma, Transitional Cell

Carcinoma, Renal Cell, Melanoma, Neoplasm Metastasis

Carcinoma, Renal Cell

Prostatic Neoplasms

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis

Carcinoma, Non-Small-Cell Lung

Influenza, Human, Pancreatic Neoplasms

Carcinoma, Renal Cell, Neoplasm Metastasis

Mesothelioma, Malignant

Brain Neoplasms, Melanoma

Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumors

Hodgkin Disease

Carcinoid Tumor, Neuroendocrine Tumors

Uveal Melanoma, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Pancreatic Neoplasms

Carcinoma, Transitional Cell

Multiple Myeloma

Lung Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies

TOP2101

Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)

PORTSIDE

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC

ATLAS

Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC

Nivolumab Combined With BMS-986253 in HCC Patients

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

CLAUDE

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)

A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC

CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

ADAPTeR

Induction Chemo-Nivo in Unresectable Stage III NSCLC

A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer

NivoMet

Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma

High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma

ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

INFLUENCE

ERICA

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

CA209-322

Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

NIMBLe

Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS

Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors

ENSIGN

CHECKPOINT

A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma

Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer